Echo Partners focuses exclusively on healthcare and life sciences, providing independent financial and strategic advice to clients in these industries. We deliver senior-level attention and a long-term perspective across our three core service areas:
We advise healthcare and life science companies on raising capital through private channels. This includes guiding clients in securing growth equity, venture financing, or debt funding from strategic investors and financial institutions. Our team leverages deep industry networks and market insight to help optimize capital structure and ensure each financing aligns with our client’s long-term objectives. The result is a tailored capital solution delivered with discretion and trust.
Echo Partners provides sophisticated M&A advisory for buyers and sellers in the healthcare and life sciences space. Our bankers have extensive experience executing acquisitions, divestitures, partnerships, and exit transactions. We offer unbiased counsel at every step – from strategic planning and valuation through due diligence, negotiation, and closing. Our collaborative approach and rigorous analysis help clients achieve optimal outcomes while preserving the relationships and integrity critical for long-term success.
We serve as long-term strategic advisors beyond any single transaction. Echo’s team works closely with executives and boards to navigate pivotal decisions such as growth initiatives, portfolio strategy, and response to industry change. We bring an objective perspective informed by deep sector knowledge, helping clients evaluate new opportunities or challenges – whether it’s assessing a potential partnership, preparing for market disruptions, or responding to unsolicited offers. Our advice is candid, trusted, and always aligned with the client’s best interests.
Our exclusive focus on healthcare and life sciences spans a broad range of verticals. We are experienced in advising companies across:
Instruments, reagents and software platforms that accelerate target discovery and assay development.
Contract development, manufacturing and research organizations that enable drug and device pipelines.
Design and development of medical devices, implants and therapeutic delivery systems.
Assay, imaging and point-of-care test developers for disease detection and monitoring.
Companies creating biologic therapies, genetic medicines and cell-based treatment platforms.
Small-molecule and specialty drug developers overseeing discovery, development and distribution.
Computational analysis and software tools transforming genomic and clinical data into insights.
Digital platforms, telemedicine and software solutions that enhance care delivery and engagement.
Clinical care, diagnostics and support services providers across outpatient and inpatient settings.
By concentrating on these sectors, Echo Partners combines specialized industry insight with financial expertise, ensuring advice that resonates with the unique dynamics of each vertical.
Sign up to receive our latest industry insights, news, and more.